Cencora, Inc. (COR) is a Consumer Discretionary stock trading at $271.89 (as of 2026-06-18), with a market capitalization of $52.41B and a trailing P/E of 21.6. Figures are sourced from first-party U.S. SEC EDGAR filings and market data.
Cencora, Inc. supplies and distributes pharmaceutical products internationally and in the United States. Its segments include distribution and related services for U.S. healthcare providers and retail pharmacies, and offerings supporting biopharmaceutical and healthcare customers such as supply management and software, clinical trial and commercialization support, packaging, and analytics.